Skip to Main Content

Paper Details

Phase II trial of cytarabine and mitoxantrone with devimistat in acute myeloid leukemia.
Nat Commun
11
2022
AML, ATP, Devimistat, RNA, acute myeloid leukemia, cytarabine, devimistat, mitochondrial gene sets, mitoxantrone, oxygen, patient, patients
Author NameAffiliation
Lance D MillerComprehensive Cancer Center of Atrium Health Wake Forest Baptist
Jeff W Chou
Timothy S PardeeComprehensive Cancer Center of Atrium Health Wake Forest Baptist
Timothy S PardeeComprehensive Cancer Center of Atrium Health Wake Forest Baptist
Timothy S PardeeRafael Pharmaceuticals Inc
  • 1 - 5

Datasets

Release 1.2